| Page 6 | Kisaco Research
AI Data Center Track - Sample Attendee List
  • Explore how biomarker-driven approaches are streamlining trial design, improving patient stratification, and accelerating time-to-approval for women’s health therapeutics.
  • Learn how collaborations between industry, academia, biotech, and pharma are turning early-stage biomarker insights into clinically actionable endpoints.
  • How to maximise the use of biobanks in biomarker discovery.

Author:

Sanj Singh

CEO
Temple Therapeutics

Sanj Singh

CEO
Temple Therapeutics
 

Sanj Singh

CEO
Temple Therapeutics

Sanj Singh

CEO
Temple Therapeutics

Sanj Singh

CEO
Temple Therapeutics
  • Explore how biomarker-driven approaches are streamlining trial design, improving patient stratification, and accelerating time-to-approval for women’s health therapeutics.
  • Learn how collaborations between industry, academia, biotech, and pharma are turning early-stage biomarker insights into clinically actionable endpoints.
  • How to maximise the use of biobanks in biomarker discovery.

Author:

Sanj Singh

CEO
Temple Therapeutics

Sanj Singh

CEO
Temple Therapeutics
 

Cindy Rahman

President & CEO
March of Dimes

Cindy Rahman

President & CEO
March of Dimes

Cindy Rahman

President & CEO
March of Dimes
Enterprise AI - Sample Attendee List
 

Sheeva Talebian

Reproductive Endocrinologist
CCRM New York

Sheeva Talebian

Reproductive Endocrinologist
CCRM New York

Sheeva Talebian

Reproductive Endocrinologist
CCRM New York